Circulating tumour cells as prognostic biomarkers in colorectal cancer: a systematic review
Veyrune, Léa Naumann, David N Christou, Niki
Veyrune, Léa
Naumann, David N
Christou, Niki
Abstract
Despite therapeutic advances, colorectal cancer (CRC) is still one of the deadliest cancers, partly due to local recurrence and metastatic disease. Tumour cells that spread by gaining access to peripheral blood are called circulating tumour cells (CTCs). These may be present before there are any clinical signs, but can be detected within blood samples. CTCs from patients with CRC may be isolated in a laboratory for characterization and multiple analyses. In this review, we focus on the prognostic potential of CTCs detection, by evaluating the reported progress and applications of such analyses. Our search found 77 relevant studies that reported CTC detection in CRC. Both cell count and features were reported as promising prognosis biomarkers. Since CTCs are rare and can lose their differentiation, new tools are being developed to improve detection. CTCs may have potential as prognostic biomarkers for CRC in terms of survival prediction, anticipating chemotherapy resistance, and surgical planning. CTCs are not yet used in clinical practice, and further investigations are required in order to better frame their practical value.
MIDER Authors
Affiliations
University Hospital Limoges; University Hospitals Birmingham NHS Foundation Trust; University of Limoges
Date
2021-04-08
Type
Article
Collections
Citation
Veyrune L, Naumann DN, Christou N. Circulating Tumour Cells as Prognostic Biomarkers in Colorectal Cancer: A Systematic Review. Int J Mol Sci. 2021 Apr 8;22(8):3437. doi: 10.3390/ijms22083437.